First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells
Researchers from The University of Texas MD Anderson Cancer Center have developed a first-in-class antibody that targets a protein overexpressed in many cancer types, allowing for the creation of a new radio-theranostic treatment ...
Apr 1, 2026
0
3









